Arthur Eichengrün the invention of aspirin in 1897. Impure acetylsalicylic acid (ASA, the active compound of aspirin) had been synthesized already in 1853 by French chemist Charles Frédéric Gerhardt; the 1897 process developed at Bayer was the first to produce pure ASA that could be used for medical purposes. Due to the rise of the Nazis in Germany, Eichengrün was unable to object when Hoffman first made the claim that "he" (Hoffman) invented aspirin, in the footnote of a 1934 German Encyclopedia. Hoffman's claim was once widely accepted, but many historians now consider it to be discredited. Eichengrün first claimed to have
Generic trademark A different sense of the word "genericized" in the pharmaceutical industry refers to products whose patent protection has expired. For example, Lipitor was genericized in the U.S. when the first competing generic version was approved by the FDA in November 2011. In this same context, the term "genericization" refers to the process of a brand drug losing market exclusivity to generics. Trademark erosion, or genericization, is a special case of antonomasia related to trademarks. It happens when a trademark becomes so common that it starts being used as a common name "and" the original company has failed to prevent such